Up-regulated expression of genes encoding Hrk and IL-3R beta subunit by TCDD in vivo and in vitro

Joo-Hung Park1, Soo-Woong Lee

  • 1Department of Biology, Changwon National University, #9 Sarim-dong, Changwon, Kyungnam 641-773, South Korea. parkjh@sarim.changwon.ac.kr

Toxicology Letters
|March 7, 2002
PubMed

Insights

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) causes immunosuppression by regulating genes like Hrk and IL-3R beta. This study identifies potential molecular mechanisms and an in vitro model for thymic atrophy.

Area of Science:

  • Toxicology
  • Immunology
  • Molecular Biology

Background:

  • 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is known for immunosuppressive effects.
  • The precise molecular mechanisms underlying TCDD's immunosuppression are not fully understood, partly due to its limited in vitro activity.

Purpose of the Study:

  • To investigate the molecular mechanisms of TCDD-induced immunosuppression.
  • To identify genes regulated by TCDD in vivo using a mouse tumor model.

Main Methods:

  • Gene expression profiling using DNA arrays on RNA from lymphoid organs of TCDD-treated mice.
  • Reverse transcription PCR (RT-PCR) and Western blot analyses to confirm gene expression changes.
  • In vitro experiments using Jurkat T cells to study TCDD effects on specific genes.

Main Results:

  • TCDD treatment modulated the expression of several genes, including Hrk and IL-3R beta (AIC-2A), in addition to previously identified genes like NF-kappa B p65 and p27(Kip1).
  • Differential expression of Hrk and IL-3R beta was confirmed by RT-PCR and Western blot.
  • Hrk expression was upregulated by TCDD in Jurkat T cells.

Conclusions:

  • Hrk may play a role in TCDD-induced thymic atrophy.
  • Jurkat T cells show potential as an in vitro model for studying the mechanisms of thymic atrophy caused by TCDD.